Kalipso Chalkidou

Kalipso Chalkidou (born in 1977) is a Professor of Public Health at Imperial College London and Director of Global Health Policy at the Center for Global Development. Her research considers how local expertise can inform the allocation of scientific and healthcare resources.

Kalipso Chalkidou
Chalkidou speaks at the Center for Strategic & International Studies in 2015
Born1977 (age 43–44)
Alma materNewcastle University
National and Kapodistrian University of Athens
Scientific career
InstitutionsImperial College London
National Institute for Health and Care Excellence
London School of Hygiene & Tropical Medicine
Johns Hopkins Bloomberg School of Public Health

Early life and education

Chalkidou was born in Greece. Her earliest ambition was to become a train driver.[1] Instead, Chalkidou became a physician. She originally studied medicine at the National and Kapodistrian University of Athens.[2] She completed a doctoral degree in molecular biology at Newcastle University. She has said that one of her greatest inspirations was Che Guevara.[1] Whilst completing her doctoral research, Chalkidou completed her clinical rotations in basic surgery. Her research considered novel therapies for prostate cancer.

Research and career

After earning her doctorate Chalkidou joined National Institute for Health and Care Excellence (NICE) as Associate Director of Research. In this capacity, she evaluated novel healthcare technologies and reviewed the social value judgements of the NICE committees.[3] She held an honorary position at the London School of Hygiene & Tropical Medicine, where she studied applications of pharmacoeconomics in Japan.[3]

In 2007 Chalkidou joined the Johns Hopkins Bloomberg School of Public Health, where she was made a Harkness fellow in Health Policy and Practice.[3][4] As part of her fellowship, Chalkidou studied how to translate evidence into a research agenda.[3] She argued that healthcare decision making should be rooted in research policies.[5] On her return to the United Kingdom Chalkidou helped to set up National Institute for Health and Care Excellence (NICE) International.[6] Here she established the International Decision Support Initiative (IDSI), a network of policy makers, researchers and development experts which was largely funded by the Bill & Melinda Gates Foundation.

Chalkidou moved to Imperial College London in 2016.[7] In 2018 Bill & Melinda Gates Foundation awarded Chalkidou and IDSI a $14.5 million grant to expand healthcare access in the developing world.[8] IDSI works with governments in the developing world to support their health policy, looking to achieve value-for-money in the medical decision making.[8] With IDSI, Chalkidou led national health reform programmes in Colombia, India and the Middle East.[9] She supported Tanzania in their prioritisation list of essential medicines, which freed up essential resources for more effective treatments.

Chalkidou is Director of Global Health Policy at the Center for Global Development.[9] Her research focusses on helping governments improve health policy.[10][11]

From 2019, she was a research lead at the Jameel Institute for Disease and Emergency Analytics (J-IDEA) at Imperial.[12]

She was appointed to the Board of Directors at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in 2020.[13]

Select publications
  • Thorpe, Kevin E.; Zwarenstein, Merrick; Oxman, Andrew D.; Treweek, Shaun; Furberg, Curt D.; Altman, Douglas G.; Tunis, Sean; Bergel, Eduardo; Harvey, Ian; Magid, David J.; Chalkidou, Kalipso (2009-05-01). "A pragmatic–explanatory continuum indicator summary (PRECIS): a tool to help trial designers". Journal of Clinical Epidemiology. 62 (5): 464–475. doi:10.1016/j.jclinepi.2008.12.011. ISSN 0895-4356.
  • Halkidou, Kalipso; Gaughan, Luke; Cook, Susan; Leung, Hing Y.; Neal, David E.; Robson, Craig N. (2004). "Upregulation and Nuclear Recruitment of HDAC1 in Hormone Refractory Prostate Cancer". The Prostate. 59 (2): 177–189. doi:10.1002/pros.20022. ISSN 1097-0045.
  • Brownlee, Shannon; Chalkidou, Kalipso; Doust, Jenny; Elshaug, Adam G; Glasziou, Paul; Heath, Iona; Nagpal, Somil; Saini, Vikas; Srivastava, Divya; Chalmers, Kelsey; Korenstein, Deborah (2017-07-08). "Evidence for overuse of medical services around the world". The Lancet. 390 (10090): 156–168. doi:10.1016/S0140-6736(16)32585-5. ISSN 0140-6736.

References
  1. Group, British Medical Journal Publishing (2016-07-29). "Kalipso Chalkidou: Internationally NICE". BMJ. 354. doi:10.1136/bmj.i4129. ISSN 1756-1833. PMID 27474760.
  2. "Institute of Cancer Policy :: Kalipso Chalkidou". instituteofcancerpolicy.org. Retrieved 2020-07-10.
  3. "Kalipso Chalkidou | Commonwealth Fund". www.commonwealthfund.org. Retrieved 2020-07-10.
  4. "Kalipso Chalkidou: Priority Setting Institutions in Health: Why and How? | Johns Hopkins Berman Institute of Bioethics". Retrieved 2020-07-10.
  5. Chalkidou, Kalipso; Lord, Joanne; Fischer, Alastair; Littlejohns, Peter (2008). "Evidence-based decision making: when should we wait for more information?". Health Affairs (Project Hope). 27 (6): 1642–1653. doi:10.1377/hlthaff.27.6.1642. ISSN 1544-5208. PMID 18997223.
  6. "Professor Kalipso Chalkidou - Networks of evidence and expertise for public policy". www.csap.cam.ac.uk. Retrieved 2020-07-10.
  7. "NICE global care experts move to Imperial | News and features | News". NICE. Retrieved 2020-07-10.
  8. "$14.5m Gates Foundation grant to help improve global healthcare". www.myscience.uk. 2020-05-29. Retrieved 2020-07-10.
  9. "Kalipso Chalkidou". Center For Global Development. Retrieved 2020-07-10.
  10. "Kalipso Chalkidou". iDSI. 2017-08-31. Retrieved 2020-07-10.
  11. "Meet our team". iDSI. 2016-04-08. Retrieved 2020-07-10.
  12. "People". Imperial College London. Retrieved 2020-11-18.
  13. "ISPOR Announces 2020-2021 Board of Directors". www.newswise.com. Retrieved 2020-07-10.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.